These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7660832

  • 1. Electrophysiological characterization of a novel class III antiarrhythmic agent, GLG-V-13 in the mammalian heart.
    Fazekas T, Scherlag BJ, Carlsson L, Mabo P, Patterson E, Berlin KD, Lazzara R.
    Acta Physiol Hung; 1995; 83(1):13-30. PubMed ID: 7660832
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T, Carlsson L, Scherlag BJ, Mabo P, Poty H, Palmer M, Patterson E, Berlin KD, Garrison GL, Lazzara R.
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [Abstract] [Full Text] [Related]

  • 3. Class III electrophysiologic actions of imidazole-substituted diheterabicyclononanes in canine myocardium.
    Patterson E, Scherlag BJ, Sangiah S, Garrison GL, Couch KM, Berlin KD, Lazzara R.
    J Pharmacol Exp Ther; 1997 Apr; 281(1):155-62. PubMed ID: 9103493
    [Abstract] [Full Text] [Related]

  • 4. Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile force.
    Chen CL, Sangiah S, Patterson E, Berlin KD, Garrison GL, Dunn W, Nan Y, Scherlag BJ, Lazzara R.
    Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):3-16. PubMed ID: 1334277
    [Abstract] [Full Text] [Related]

  • 5. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    Wallace AA, Stupienski RF, Baskin EP, Appleby SD, Kothstein T, Gehret JR, King SW, Remy DC, Lynch JJ.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and plasma protein binding of the new potent class III antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate.
    Chen CL, Sangiah S, Roder JD, Chen H, Berlin KD, Garrison GL, Scherlag BJ, Lazzara R.
    Arzneimittelforschung; 1995 Jun; 45(6):670-5. PubMed ID: 7646568
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiologic actions of d,l-sotalol and GLG-V-13 in ischemically injured canine epicardium.
    Patterson E, Scherlag BJ, Lazzara R, Garrison GL, Berlin KD.
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):304-13. PubMed ID: 17878760
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiological actions of BRB-I-28 in canine myocardial tissues.
    Patterson E, Scherlag BJ, Berlin KD, Lazzara R.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):558-65. PubMed ID: 1941607
    [Abstract] [Full Text] [Related]

  • 9. Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
    Beatch GN, Abraham S, MacLeod BA, Yoshida NR, Walker MJ.
    Br J Pharmacol; 1991 Jan; 102(1):13-8. PubMed ID: 2043919
    [Abstract] [Full Text] [Related]

  • 10. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
    Bargheer K, Bode F, Klein HU, Trappe HJ, Franz MR, Lichtlen PR.
    Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
    [Abstract] [Full Text] [Related]

  • 11. Investigations to characterize a new antiarrhythmic drug bisaramil.
    Paroczai M, Karpati E.
    Pharmacol Res; 1991 Aug; 24(2):149-62. PubMed ID: 1684242
    [Abstract] [Full Text] [Related]

  • 12. Novel 3,7-diheterabicyclo[3.3.1]nonanes that possess predominant class III antiarrhythmic activity in 1-4 day post infarction dog models: X-ray diffraction analysis of 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3,7-diazabicyclo[3.3.1]nona ne dihydroperchlorate.
    Garrison GL, Berlin KD, Scherlag BJ, Lazzara R, Patterson E, Fazekas T, Sangiah S, Chen CL, Schubot FD, van der Helm D.
    J Med Chem; 1996 Jun 21; 39(13):2559-70. PubMed ID: 8691454
    [Abstract] [Full Text] [Related]

  • 13. Electrophysiological effects of SD-3212, a novel antiarrhythmic agent, on rabbit hearts in vivo and in vitro.
    Takahashi N, Ito M, Ishida S, Fujino T, Maruyama T, Saikawa T.
    J Cardiovasc Pharmacol; 1995 Jun 21; 25(6):1006-11. PubMed ID: 7564327
    [Abstract] [Full Text] [Related]

  • 14. Effect of GLG-V-13, a class III antiarrhythmic agent, on potassium currents in rabbit ventricular myocytes.
    Virág L, Fazekas T, Iost N, Varró A, Berlin KD, Scherlag BJ, Lazzara R, Pap JG.
    Life Sci; 2000 Mar 21; 66(17):PL 253-8. PubMed ID: 11261597
    [Abstract] [Full Text] [Related]

  • 15. Inotropic and electrophysiological effects of AB--2, a new antiarrhythmic agent, on isolated cardiac preparations.
    Beresewicz A, Pytkowski B, Sedek G, Zdanowski K.
    Pol J Pharmacol Pharm; 1983 Mar 21; 35(3):223-32. PubMed ID: 6651921
    [Abstract] [Full Text] [Related]

  • 16. RSD1019 suppresses ischaemia-induced monophasic action potential shortening and arrhythmias in anaesthetized rabbits.
    Barrett TD, MacLeod BA, Walker MJ.
    Br J Pharmacol; 2000 Oct 21; 131(3):405-14. PubMed ID: 11015289
    [Abstract] [Full Text] [Related]

  • 17. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
    Lynch JJ, Wallace AA, Stupienski RF, Baskin EP, Beare CM, Appleby SD, Salata JJ, Jurkiewicz NK, Sanguinetti MC, Stein RB.
    J Pharmacol Exp Ther; 1994 May 21; 269(2):541-54. PubMed ID: 7802864
    [Abstract] [Full Text] [Related]

  • 18. Class III antiarrhythmic action linked with positive inotropy: antiarrhythmic, electrophysiological, and hemodynamic effects of the sea-anemone polypeptide ATX II in the dog heart in situ.
    Platou ES, Refsum H, Hotvedt R.
    J Cardiovasc Pharmacol; 1986 May 21; 8(3):459-65. PubMed ID: 2425158
    [Abstract] [Full Text] [Related]

  • 19. Attenuation of KATP channel-opener induced shortening of repolarization time by alpha 1-adrenoceptor antagonist during ischemia in canine heart.
    Tanabe T, Aikawa M, Deguchi Y, Yoshioka K, Handa S.
    Cardiovasc Drugs Ther; 2000 Jun 21; 14(3):283-94. PubMed ID: 10935150
    [Abstract] [Full Text] [Related]

  • 20. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
    Lynch JJ, Wallace AA, Van der Gaag LH, Baskin EP, Bear CM, Gehret JR, Kothstein T, Stupienski RF, Appleby SD, Sanguinetti MC.
    J Pharmacol Exp Ther; 1993 May 21; 265(2):720-30. PubMed ID: 8496818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.